• Home
  • Terms of Use
  • Privacy Policy
  • Disclosure
Saturday, June 25, 2022
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
Omicron b11529 Variant
No Result
View All Result
Home Omicron Variant

New Omicron Variants Target Lungs And Escape Antibodies – Deseret News

by NewsReporter
June 22, 2022
in Omicron Variant
Reading Time: 2 mins read
Share on FacebookShare on Twitter

Omicron variants are driving new infections across the world, proving to evade antibodies.

Why it matters: Preliminary research from the University of Tokyo suggests that the alpha and delta strains produced more severe illnesses compared to omicron, which creates cold or allergy-like symptoms, per The Independent.

But this research reveals something more important — the new omicron variants have evolved to target lung cells again, drawing similarities to its origin strains.

What they’re saying: The risk that strains BA.4 and BA.5 pose “to global health is potentially greater than that of original BA.2,” said Dr. Kei Sato, the study’s lead author, per The Guardian.

“It looks as though these things are switching back to the more dangerous form of infection, so going lower down in the lung,” said Dr. Stephen Griffin, a virologist at the University of Leeds, per the report.

By the numbers: Earlier in June, the BA.4 and BA.5 only constituted 6% and 7% of all cases in the U.S., respectively. Three weeks later, the BA.5 strain alone makes up 23.5% of cases in the U.S., while BA.4 has a hold on 11.4%, according to the Centers for Disease Control and Prevention tracker.

Do vaccines work?: Industry experts in Japan, scientists in South Africa and researchers at Columbia University all concluded that the vaccines and prior infections offer less protection against the newest strains, BA.4 and BA.5, compared to older omicron strains like BA.1 and BA.2, wrote Betsy Ladyshets for Time magazine.

Worth noting: South Africa has already experienced the wave from the BA.4 and BA.5 variants, which turned out to be less deadly. Tulio de Oliveira, the director of the Centre for Epidemic Response and Innovation at Stellenbosch University in South Africa, said the wave may have been less deadly because hospitals were empty and ready to receive patients or because the population already had a strong immunity, whether through vaccines or previous infection, per The Guardian.

Symptoms for omicron can appear from two to 14 days after exposure.

  • The symptoms for BA.4 and BA.5 are mostly mild, including fever, tiredness and a loss of smell, as I previously reported.

Related Posts

covid-19-variant-shot-from-sanofi,-gsk-effective-against-omicron-–-the-wall-street-journal

Covid-19 Variant Shot From Sanofi, GSK Effective Against Omicron – The Wall Street Journal

by NewsReporter
June 25, 2022
0

LONDON—GSK PLC and Sanofi SA reported promising trial results for their Covid-19 vaccine that showed the shot—developed to target the Beta strain of the virus—was particularly effective against the Omicron variant.The two companies said Friday that in a trial involving 13,000 adults, the vaccine demonstrated efficacy of 64.7% against symptomatic...

the-next-covid-booster-shots-will-likely-be-updated-for-omicron-–-edmonton-journal

The Next COVID Booster Shots Will Likely Be Updated For Omicron – Edmonton Journal

by NewsReporter
June 25, 2022
0

Author of the article: A nurse inoculates a man with a booster dose of vaccine against COVID-19 on Feb. 15, 2022. Photo by ALFREDO ESTRELLA / AFP NEW YORK — COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original...

analysis:-the-next-covid-booster-shots-will-likely-be-updated-for-omicron-–-reuters.com

Analysis: The Next COVID Booster Shots Will Likely Be Updated For Omicron – Reuters.com

by NewsReporter
June 24, 2022
0

REUTERS/Hannah BeierRegister now for FREE unlimited access to Reuters.comNEW YORK (Reuters) - COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original strain, although some experts suggest they may only offer significant benefits for older and immunocompromised people.Moderna, Pfizer and...

BioMarin’s Hemophilia Gene Therapy Roctavian Wins Conditional EU Backing Amid FDA Delay – FiercePharma

by NewsReporter
June 24, 2022
0

Please enable cookies. We are checking your browser... www.fiercepharma.com Why do I have to complete a CAPTCHA? Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. What can I do to prevent this in the future? If you are on a personal...

Amid M&A Rumors, Merck And Seagen Set To Meet: WSJ – FiercePharma

by NewsReporter
June 24, 2022
0

Why do I have to complete a CAPTCHA? Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. What can I do to prevent this in the future? If you are on a personal connection, like at home, you can run an anti-virus...

what-experts-have-to-say-about-covid-19-in-san-diego-–-voice-of-san-diego

What Experts Have To Say About COVID-19 In San Diego – Voice Of San Diego

by NewsReporter
June 24, 2022
0

New COVID-19 cases seemed to be declining in recent days. That trend didn’t hold.  San Diego County reported more than 1,600 new positive COVID-19 tests on both Tuesday and Wednesday, bringing the numbers back up to the mid-June surge level. There were also 10 new deaths and 24 new COVID-19...

Omicron b11529 Variant

© 2021

Navigate Site

  • Home
  • Terms of Use
  • Privacy Policy
  • Disclosure

Follow Us

No Result
View All Result
  • Home

© 2021